Detalhe da pesquisa
1.
SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy.
J Med Virol
; 94(11): 5174-5188, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35765167
2.
SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
J Med Virol
; 93(9): 5376-5389, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33913550
3.
Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.
J Med Virol
; 92(11): 2693-2701, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32497323
4.
SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules.
Signal Transduct Target Ther
; 7(1): 22, 2022 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35075101
5.
An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.
Cell Chem Biol
; 29(1): 5-18.e6, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34672954
6.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.
Signal Transduct Target Ther
; 5(1): 299, 2020 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33372174
7.
Correction: A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins.
Signal Transduct Target Ther
; 6(1): 192, 2021 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33986250
8.
A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins.
Signal Transduct Target Ther
; 5(1): 269, 2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203855